Teal Cannabis

In July 2026, Teal Cannabis concentrated 37.71% of sales in Vapor Pens with a 0.61% year-over-year gain but a 3.51% month-over-month decline, while Pre-Roll held 32.05% share with a 2.86% year-over-year contraction and a 38.61% month-over-month surge. Concentrates accounted for 30.24% share with a 4.90% year-over-year decrease and a 28.41% month-over-month increase, and the brand’s overall year-over-year sales moved down 2.26% as average price rose 3.46%. Within Missouri Vapor Pens, Teal Cannabis sat at rank 58, implying that the category lead is anchored more by breadth than by rank momentum. The pattern indicates July 2026 was a mix-shift month where rapid month-over-month lifts in Pre-Roll and Concentrates offset Vapor Pens softness, but the negative year-over-year in two of three categories explains the modest brand-level decline and suggests reliance on shorter-cycle demand rather than sustained category outperformance.

With Vapor Pens still the largest slice at 37.71% yet down 3.51% month-over-month and paired with a rank of 58 in Missouri, the category’s contribution looks defensive rather than expansionary, while the 38.61% month-over-month upswing in Pre-Roll and the 28.41% month-over-month climb in Concentrates reposition the portfolio toward value-accessible and potency-driven missions. Given average price up 3.46% year-over-year alongside brand sales down 2.26%, the mix implies that recent growth pulses came from unit velocity in lower-ticket formats like Pre-Roll (average price $11.40) and from occasion-driven Concentrates ($42.86), not from premiumization in Vapor Pens ($38.76). This combination points to a positioning opportunity: lean into the high-frequency Pre-Roll channel to stabilize share while using Concentrates’ double-digit month-over-month lift to seed repeat occasions, treating Vapor Pens as a retention pillar rather than a primary growth engine.